Rare disease research operates under conditions of extreme complexity. These pressures are driving new approaches to evidence ...

Orphan drug designation from the European Commission underscores Solid’s commitment to advance SGT-003 through a global development effort for ...

Participation in state AIDS Drug Assistance Programs was associated with improved HIV treatment outcomes and high rates of viral suppression.

Texas Biomedical Research Institute has established a new $2 million Tuberculosis Innovation and Technology Fund supported by philanthropic investment to accelerate future TB discoveries, therapies ...

For Western pharmaceutical leaders, the question is no longer whether to engage Asia, but how to integrate its capabilities ...

The field of infectious disease research faces persistent challenges in bridging the gap between laboratory findings and successful clinical translation.

A new treatment for patients with life-threatening infectious diseases is being pioneered in Melbourne by researchers at The ...

Japan's House of Representatives on Tuesday approved health insurance system reform bills featuring the establishment of a ...

Patent expirations are increasingly concentrated in specialty, with >$43B in 2026 brand sales exposed and meaningful ...

Researchers at McMaster University have developed a new generative artificial intelligence (AI) model capable of drastically speeding up drug discovery—and, in early tests, it has already designed a ...

The FDA has recently approved multiple veterinary drugs targeting conditions from pain and inflammation to parasitic infections, reflecting rapid innovation in animal health. Advances include novel ...

Novellia, the only real-world data company built entirely on information patients choose to contribute to medical research, today announced it has won the 2026 Fierce Outsourcing Award for Innovation ...